SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-004083
Filing Date
2024-01-29
Accepted
2024-01-29 09:06:07
Documents
22
Period of Report
2024-01-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 49545
2 ex10-1.htm EX-10.1 142383
3 ex10-2.htm EX-10.2 7946
4 ex10-3.htm EX-10.3 91029
5 ex10-4.htm EX-10.4 88254
6 ex10-5.htm EX-10.5 76288
7 ex99-1.htm EX-99.1 19349
8 ex10-4_001.jpg GRAPHIC 6605
9 ex99-1_001.jpg GRAPHIC 4139
  Complete submission text file 0001493152-24-004083.txt   753179

Data Files

Seq Description Document Type Size
10 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rnxt-20240129.xsd EX-101.SCH 3015
11 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rnxt-20240129_lab.xml EX-101.LAB 34240
12 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rnxt-20240129_pre.xml EX-101.PRE 22359
23 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3398
Mailing Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110
Business Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

IRS No.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40738 | Film No.: 24570621
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)